Phase I study of replication-competent adenovirus-mediated double suicide gene therapy in combination with three-dimensional conformal radiation therapy for the treatment of locally aggressive prostate cancer

被引：0
|
作者：
Freytag, SO [1 ]
Stricker, H [1 ]
Pegg, J [1 ]
Paielli, D [1 ]
Xia, S [1 ]
Brown, S [1 ]
Kim, JH [1 ]
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
820
引用
下载
收藏
页码：S316 / S316
页数：1
相关论文
共 50 条
  • [31] Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study
    Zhao, Jian-Dong
    Liu, Jin
    Ren, Zhi-Gang
    Gu, Ke
    Zhou, Zhen-Hua
    Li, Wen-Tao
    Chen, Zhen
    Xu, Zhi-Yong
    Liu, Lu-Ming
    Jiang, Guo-Liang
    RADIATION ONCOLOGY, 2010, 5
  • [32] Re: Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy with or without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 193 (03): : 847 - 847
  • [33] Replication Competent Adenovirus-mediated cytotoxic and Interleukin-12 Gene Therapy in Stage IV Pancreatic Cancer: 36 Month Follow-Up Data from a Phase I Clinical Trial
    Nyati, Shyam
    Siddiqui, Farzan
    Barton, Kenneth
    Pompa, Robert
    Freytag, Svend O.
    Khan, Gazala
    Dobrosotskaya, Irina
    Ajlouni, Munther
    Zhang, Yingshu
    Cheng, Jingfang
    Brown, Stephen
    Movsas, Benjamin
    Kwon, David
    MOLECULAR THERAPY, 2022, 30 (05) : 5 - 5
  • [34] A phase I/II study of adenovirus-mediated reduced expression in immortalized cells (REIC/DKK-3) gene therapy for prostate cancer: An interim report.
    Sasaki, Katsumi
    Nasu, Yasutomo
    Watanabe, Masami
    Kaku, Haruki
    Tanimoto, Ryuta
    Kanbara, Daiki
    Watanabe, Toyohiko
    Yanai, Hiroyuki
    Kumon, Hiromi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [35] A phase II trial of accelerated hypofractionated three-dimensional conformal radiation therapy in locally advanced non-small cell lung cancer
    Zhu, Zheng-Fei
    Fan, Min
    Wu, Kai-Liang
    Zhao, Kuai-Le
    Yang, Huan-Jun
    Chen, Gui-Yuan
    Jiang, Guo-Liang
    Wang, Li-Juan
    Zhao, Sen
    Fu, Xiao-Long
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (03) : 304 - 308
  • [36] A PHASE II TRIAL OF ACCELERATED HYPOFRACTIONATED THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
    Zhu, Zheng-Fei
    Fan, Min
    Wu, Kai-Liang
    Zhao, Kuai-Le
    Yang, Huan-Jun
    Chen, Gui-Yuan
    Jiang, Guo-Liang
    Wang, Li-Juan
    Zhao, Sen
    Fu, Xiao-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S790 - S791
  • [37] The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?
    Levitt, SH
    Khan, FM
    JOURNAL OF UROLOGY, 2002, 168 (01): : 377 - 377
  • [38] The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?
    Levitt, SH
    Khan, FM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04): : 871 - 879
  • [39] Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer
    Sim, S
    Rosenzweig, KE
    Schindelheim, R
    Ng, KK
    Leibel, SA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03): : 660 - 665
  • [40] Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy, Dynamic Intensity Modulated Radiation Therapy, and Hybrid Planning for Treatment of Locally Advanced Lung Cancer
    Basaran, Hamit
    Inan, Gokcen
    Gul, Osman Vefa
    Duzova, Mursel
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (03) : 523 - 530
12345